Accelerate Development with Lannett CDMO - Streamlined development of oral solid dose formulations - Extensive expertise and high-volume manufacturing - Commitment to quality and regulatory compliance Our track record speaks volumes - 17 approved product applications since 2019 - 96% average product yield rate - Zero critical FDA Form 483 observations Learn More About Partnering with Lannett. https://www.lannettcdmo.com/

Did you know? The total GLP-1 market is projected to reach a potential $200 billion by 2031. As such, oral solid dose (OSD) formulations are poised to gain significant traction. This shift demands manufacturing partners with proven expertise in: 💊Specialized potent compound handling ⏳ Modified release technology 🎯 Precise quality control systems 📈 Continuity of supply https://www.lannettcdmo.com/advanced-formulation-analytical-services/

We offer adaptable manufacturing options to accommodate varying production scales and timelines for our partners. Contact us to find out more- https://www.lannettcdmo.com/pharmaceutical-manufacturing/

Outsourcing to a CDMO can significantly reduce operational costs and increase efficiency. By partnering with Lannett CDMO, companies can leverage our expertise and infrastructure, allowing them to focus on their core competencies. https://pharma-contractor-manufacturer.mystrikingly.com/blog/the-growing-importance-of-pharma-contract-manufacturing-services-88ea68f0-e173-424a-91ed-90f889848b0f #PharmaOutsourcing #OperationalEfficiency #CostReduction #PharmaceuticalManufacturing#BusinessPartnership #Lannett #LannettCDMO

Accelerate Your Drug to Market. Overcome development challenges and speed up your launch with a good CDMO partnership. Discover how a CDMO partnership can help overcome development challenges and speed up market launch. https://www.lannettcdmo.com/pharmaceutical-contract-manufacturer/

Navigating the Complex World of Pharmaceutical Regulatory Support https://www.lannettcdmo.com/regulatory-support/

Behind every pill lies meticulous precision and unwavering commitment to quality. Welcome to the heart of pharmaceutical manufacturing. https://www.lannettcdmo.com/

Lannett CDMO utilizes wet high-shear granulation. This is when a liquid binder is added to the powder mixture to form granules. This process can be used for producing: Tablets: For granules with good flow properties and compressibility. Capsules: For uniformity and flowability for capsule filling. Controlled Release: For specific release profiles with set parameters and properties. Got a particular Oral Solid Dosage form in mind? Talk to us to find out more. https://www.lannettcdmo.com/advanced-formulation-analytical-services/ #capsulefilling #granules #cdmo #oralsoliddosage #lannett #lannettcdmo

Lannett CDMO utilizes wet high-shear granulation. This is when a liquid binder is added to the powder mixture to form granules. This process can be used for producing: Tablets: For granules with good flow properties and compressibility. Capsules: For uniformity and flowability for capsule filling. Controlled Release: For specific release profiles with set parameters and properties. Got a particular Oral Solid Dosage form in mind? Talk to us to find out more. https://www.lannettcdmo.com/advanced-formulation-analytical-services/

Lannett’s laboratories are well-equipped and spacious; our walk-in and reach-in stability chambers can be validated at a variety of conditions, the common being: - Long-term (25°C and 60%RH or 25°C and 40%RH) - Intermediate (30°C and 65% RH) - Accelerated (40°C and 75%RH or 40°C and 25%RH) Our laboratory capabilities are all about providing solutions fitted to your needs. https://www.lannettcdmo.com/advanced-formulation-analytical-services/